Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Amnon Hoffman
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Procedures
Physiology
Concepts & Ideas
Disorders
Anatomy
Sign-in to see full Profile
Network (preview)
14
Friedman, Michael
13
Stepensky, David
9
Dahan, Arik
8
Benita, Simon
8
Gershkovich, Pavel
6
Perlstein, Itay
6
Klausner, Eytan
6
Lavy, Eran
6
Gilhar, Dalia
6
Golomb, Gershon
4
Afargan, Michel
4
Duvdevani, Revital
3
Dvir, Eran
3
Breuer, Eli
3
Gilon, Chaim
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Amnon Hoffman (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Haroutiunian Simon; Ratz Yael; Rabinovich Bella; Adam Miriam; Hoffman Amnon
Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study.
Journal of clinical pharmacology 2009;49(11):1363-9.
-
2009: Haroutiunian Simon; Lecht Shimon; Zur Arik A; Hoffman Amnon; Davidson Elyad
The challenge of pain management in patients with myasthenia gravis.
Journal of pain & palliative care pharmacotherapy 2009;23(3):242-60.
-
2009: Gershkovich Pavel; Itin Constantin; Yacovan Avihai; Amselem Shimon; Hoffman Amnon
Effect of abdominal surgery on the intestinal absorption of lipophilic drugs: possible role of the lymphatic transport.
Translational research : the journal of laboratory and clinical medicine 2009;153(6):296-300.
-
2009: Kagan Leonid; Lavy Eran; Hoffman Amnon
Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat model.
Pulmonary pharmacology & therapeutics 2009;22(3):260-5.
-
2009: Ginosar Y; Nadjari M; Hoffman A; Firman N; Davidson E M; Weiniger C F; Rosen L; Weissman C; Elchalal U;
Antepartum continuous epidural ropivacaine therapy reduces uterine artery vascular resistance in pre-eclampsia: a randomized, dose-ranging, placebo-controlled study.
British journal of anaesthesia 2009;102(3):369-78.
-
2009: Gershkovich Pavel; Fanous Joseph; Qadri Bashir; Yacovan Avihai; Amselem Shimon; Hoffman Amnon
The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons.
The Journal of pharmacy and pharmacology 2009;61(1):31-9.
-
2008: Kagan Leonid; Hoffman Amnon
Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations.
Expert opinion on drug delivery 2008;5(6):681-92.
-
2008: Hoffman Amnon; Qadri Bashir
Eligen insulin--a system for the oral delivery of insulin for diabetes.
IDrugs : the investigational drugs journal 2008;11(6):433-41.
-
2008: Kagan Leonid; Hoffman Amnon
Selection of drug candidates for gastroretentive dosage forms: pharmacokinetics following continuous intragastric mode of administration in a rat model.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(1):238-46.
-
2008: Hoffman Amnon; Qadri Bashir; Frant Julia; Katz Yiffat; Bhusare Sudhakar R; Breuer Eli; Hadar Rivka; Reich Reuven
Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.
Journal of medicinal chemistry 2008;51(5):1406-14.
-
2008: Hoffman Amnon; Horwitz Ehud; Hess Shmuel; Cohen-Poradosu Ronit; Kleinberg Lilach; Edelberg Anna; Shapiro Mervyn
Implications on emergence of antimicrobial resistance as a critical aspect in the design of oral sustained release delivery systems of antimicrobials.
Pharmaceutical research 2008;25(3):667-71.
-
2008: Hess Shmuel; Linde Yaniv; Ovadia Oded; Safrai Eli; Shalev Deborah E; Swed Avi; Halbfinger Efrat; Lapidot Tair; Winkler Ilan; Gabinet Yael; Faier Avi; Yarden Dana; Xiang Zhimin; Portillo Federico P; Haskell-Luevano Carrie; Gilon Chaim; Hoffman Amnon
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.
Journal of medicinal chemistry 2008;51(4):1026-34.
-
2008: Dahan Arik; Duvdevani Revital; Shapiro Israel; Elmann Anat; Finkelstein Elena; Hoffman Amnon
The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration.
Journal of controlled release : official journal of the Controlled Release Society 2008;126(1):1-9.
-
2008: Linde Yaniv; Ovadia Oded; Safrai Eli; Xiang Zhimin; Portillo Federico P; Shalev Deborah E; Haskell-Luevano Carrie; Hoffman Amnon; Gilon Chaim
Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides.
Biopolymers 2008;90(5):671-82.
-
2007: Dahan Arik; Mendelman Avivit; Amsili Sofia; Ezov Nathan; Hoffman Amnon
The effect of general anesthesia on the intestinal lymphatic transport of lipophilic drugs: comparison between anesthetized and freely moving conscious rat models.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;32(4-5):367-74.
-
2007: Hess Shmuel; Ovadia Oded; Shalev Deborah E; Senderovich Hanoch; Qadri Bashir; Yehezkel Tamar; Salitra Yoseph; Sheynis Tania; Jelinek Raz; Gilon Chaim; Hoffman Amnon
Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
Journal of medicinal chemistry 2007;50(24):6201-11.
-
2007: Kagan Leonid; Gershkovich Pavel; Mendelman Avivit; Amsili Sofia; Ezov Nathan; Hoffman Amnon
The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(3):759-65.
-
2007: Gershkovich Pavel; Hoffman Amnon
Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;32(1):24-32.
-
2007: Gershkovich Pavel; Qadri Bashir; Yacovan Avihai; Amselem Shimon; Hoffman Amnon
Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;31(5):298-305.
-
2007: Dahan Arik; Hoffman Amnon
The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(1):96-105.
-
2007: Szalat Auryan; Gershkovich Pavel; Ben-Ari Alon; Shaish Aviv; Liberman Yael; Boutboul Eti; Gotkine Marc; Hoffman Amnon; Harats Dror; Leitersdorf Eran; Meiner Vardiella
Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment.
Biochimica et biophysica acta 2007;1771(7):839-44.
-
2007: Dahan Arik; Duvdevani Revital; Dvir Eran; Elmann Anat; Hoffman Amnon
A novel mechanism for oral controlled release of drugs by continuous degradation of a phospholipid prodrug along the intestine: in-vivo and in-vitro evaluation of an indomethacin-lecithin conjugate.
Journal of controlled release : official journal of the Controlled Release Society 2007;119(1):86-93.
-
2007: Gershkovich Pavel; Shtainer Daniel; Hoffman Amnon
The effect of a high-fat meal on the pharmacodynamics of a model lipophilic compound that binds extensively to triglyceride-rich lipoproteins.
International journal of pharmaceutics 2007;333(1-2):1-4.
-
2007: Dahan Arik; Hoffman Amnon
Mode of administration-dependent brain uptake of indomethacin: sustained systemic input increases brain influx.
Drug metabolism and disposition: the biological fate of chemicals 2007;35(2):321-4.
-
2007: Shavit Oren; Leshno Moshe; Goldberger Assaf; Shmueli Amir; Hoffman Amnon
It's time to choose the study design!: net benefit analysis of alternative study designs to acquire information for evaluation of health technologies.
PharmacoEconomics 2007;25(11):903-11.
-
2007: Dvir Eran; Elman Anat; Simmons Danielle; Shapiro Israel; Duvdevani Revital; Dahan Arik; Hoffman Amnon; Friedman Jonathan E
DP-155, a lecithin derivative of indomethacin, is a novel nonsteroidal antiinflammatory drug for analgesia and Alzheimer's disease therapy.
CNS drug reviews 2007;13(2):260-77.
-
2006: Dahan Arik; Hoffman Amnon
Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats.
Pharmaceutical research 2006;23(9):2165-74.
-
2006: Dvir E; Friedman J E; Lee J Y; Koh J Y; Younis F; Raz S; Shapiro I; Hoffman A; Dahan A; Rosenberg G; Angel I; Kozak A; Duvdevani R
A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl [corrected] choline], shows superior safety and similar efficacy in reducing brain amyloid beta in an Alzheimer's disease model.
The Journal of pharmacology and experimental therapeutics 2006;318(3):1248-56.
-
2006: Kagan Leonid; Lapidot Noa; Afargan Michel; Kirmayer David; Moor Eytan; Mardor Yael; Friedman Michael; Hoffman Amnon
Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans.
Journal of controlled release : official journal of the Controlled Release Society 2006;113(3):208-15.
-
2006: Bercovich Dani; Friedlander Yechiel; Korem Sigal; Houminer Asaf; Hoffman Amnon; Kleinberg Lilach; Shochat Chen; Leitersdorf Eran; Meiner Vardiella
The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia.
Atherosclerosis 2006;185(1):97-107.
-
2005: Gershkovich Pavel; Hoffman Amnon
Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;26(5):394-404.
-
2005: Hess Shmuel; Rotshild Victoria; Hoffman Amnon
Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;25(2-3):307-12.
-
2005: Dahan Arik; Hoffman Amnon
Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;24(4):381-8.
-
2004: Falk Rama; Grunwald Jacob; Hoffman Amnon; Domb Abraham J; Polacheck Itzhack
Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.
Antimicrobial agents and chemotherapy 2004;48(9):3606-9.
-
2004: Hoffman Amnon; Stepensky David; Lavy Eran; Eyal Sara; Klausner Eytan; Friedman Michael
Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms.
International journal of pharmaceutics 2004;277(1-2):141-53.
-
2003: Klausner Eytan A; Lavy Eran; Barta Miklos; Cserepes Eva; Friedman Michael; Hoffman Amnon
Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans.
Pharmaceutical research 2003;20(9):1466-73.
-
2003: Klausner Eytan A; Lavy Eran; Stepensky David; Cserepes Eva; Barta Miklos; Friedman Michael; Hoffman Amnon
Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
Journal of clinical pharmacology 2003;43(7):711-20.
-
2003: Klausner Eytan A; Lavy Eran; Friedman Michael; Hoffman Amnon
Expandable gastroretentive dosage forms.
Journal of controlled release : official journal of the Controlled Release Society 2003;90(2):143-62.
-
2003: Klausner Eytan A; Eyal Sara; Lavy Eran; Friedman Michael; Hoffman Amnon
Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs.
Journal of controlled release : official journal of the Controlled Release Society 2003;88(1):117-26.
-
2003: Stepensky David; Kleinberg Lilach; Hoffman Amnon
Bone as an effect compartment : models for uptake and release of drugs.
Clinical pharmacokinetics 2003;42(10):863-81.
-
2002: Perlstein Itay; Stepensky David; Krzyzanski Wojciech; Hoffman Amnon
A signal transduction pharmacodynamic model of the kinetics of the parasympathomimetic activity of low-dose scopolamine and atropine in rats.
Journal of pharmaceutical sciences 2002;91(12):2500-10.
-
2002: Klausner Eytan A; Lavy Eran; Stepensky David; Friedman Michael; Hoffman Amnon
Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.
Pharmaceutical research 2002;19(10):1516-23.
-
2002: Perlstein Itay; Sapir Nir; Backon Joshua; Sapoznikov Dan; Karasik Roman; Havlin Shlomo; Hoffman Amnon
Scaling vs. nonscaling methods of assessing autonomic tone in streptozotocin-induced diabetic rats.
American journal of physiology. Heart and circulatory physiology 2002;283(3):H1142-9.
-
2002: Stepensky David; Friedman Michael; Raz Itamar; Hoffman Amnon
Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(8):861-8.
-
2002: Stepensky David; Golomb Gershon; Hoffman Amnon
Pharmacokinetic and pharmacodynamic evaluation of intermittent versus continuous alendronate administration in rats.
Journal of pharmaceutical sciences 2002;91(2):508-16.
-
2001: Perlstein I; Stepensky D; Sapoznikov D; Hoffman A
Power spectral analysis of heart rate variability in rats as a quantitative tool in the PK-PD analysis of the parasympatholytic activity of atropine.
Pharmaceutical research 2001;18(8):1220-5.
-
2001: Hoffman A; Stepensky D; Ezra A; Van Gelder J M; Golomb G
Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination.
International journal of pharmaceutics 2001;220(1-2):1-11.
-
2001: Stepensky D; Friedman M; Srour W; Raz I; Hoffman A
Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(1):107-15.
-
2000: Ezra A; Hoffman A; Breuer E; Alferiev I S; Mönkkönen J; El Hanany-Rozen N; Weiss G; Stepensky D; Gati I; Cohen H; Törmälehto S; Amidon G L; Golomb G
A peptide prodrug approach for improving bisphosphonate oral absorption.
Journal of medicinal chemistry 2000;43(20):3641-52.
-
2000: Lomnicky Y; Haimov T; Luria M H; Friedman M; Hoffman A
Pharmacodynamic effects of bezafibrate and niacin combination: implications of the mode of administration.
Journal of pharmaceutical sciences 2000;89(8):1046-53.
-
2000: Perlstein I; Hoffman A
Cumulative plot of heart rate variability spectrum assesses kinetics of action of cholinergic drugs in rats.
American journal of physiology. Heart and circulatory physiology 2000;279(1):H110-5.
-
1999: Hoffman A; Perlstein I; Habib G; Pinto E; Gilhar D
The effect of cimetidine on the pharmacodynamics of theophylline-induced seizures and ethanol hypnotic activity.
Pharmacology & toxicology 1999;85(3):130-2.
-
1999: Cohen H; Alferiev I S; Mönkkönen J; Seibel M J; Pinto T; Ezra A; Solomon V; Stepensky D; Sagi H; Ornoy A; Patlas N; Hägele G; Hoffman A; Breuer E; Golomb G
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
Pharmaceutical research 1999;16(9):1399-406.
-
1999: Hoffman A; Lomnicky Y; Luria M H; Gilhar D; Friedman M
Improved lipid lowering activity of bezafibrate following continuous gastrointestinal administration: pharmacodynamic rationale for sustained release preparation of the drug.
Pharmaceutical research 1999;16(7):1093-7.
-
1999: Hoffman A; Stepensky D
Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy.
Critical reviews in therapeutic drug carrier systems 1999;16(6):571-639.
-
1998: Lomnicky Y; Friedman M; Luria M H; Raz I; Hoffman A
The effect of the mode of administration on the hypolipidaemic activity of niacin: continuous gastrointestinal administration of low-dose niacin improves lipid-lowering efficacy in experimentally-induced hyperlipidaemic rats.
The Journal of pharmacy and pharmacology 1998;50(11):1233-9.
-
1998: Hoffman A; Danenberg H D; Katzhendler I; Shuval R; Gilhar D; Friedman M
Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form.
Journal of controlled release : official journal of the Controlled Release Society 1998;54(1):29-37.
-
1997: Hoffman A; Ziv E
Pharmacokinetic considerations of new insulin formulations and routes of administration.
Clinical pharmacokinetics 1997;33(4):285-301.
-
1997: Hoffman A; Afargan M; Backon J; Perlstein I
The anticonvulsant effect of deprenyl on pentylenetetrazol-induced seizures in Lewis rats.
The International journal of neuroscience 1997;90(3-4):223-32.
-
1997: Katzhendler I; Hoffman A; Goldberger A; Friedman M
Modeling of drug release from erodible tablets.
Journal of pharmaceutical sciences 1997;86(1):110-5.
-
1995: Donbrow M; Hoffman A; Benita S
Gradation of microcapsule wall porosity by deposition of polymer mixtures (Eudragit RL and Eudragit RS). Phase separation of polymer mixtures and effects of external media and conditions on release.
Journal of microencapsulation 1995;12(3):273-85.
-
1994: Klang S H; Frucht-Pery J; Hoffman A; Benita S
Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle.
The Journal of pharmacy and pharmacology 1994;46(12):986-93.
-
1994: Hoffman A; Afargan M; Pinto E; Gilhar D; Backon J
Differential effects of various antiinflammatory drugs on theophylline neurotoxicity.
Pharmacology, biochemistry, and behavior 1994;49(2):335-9.
-
1994: Hoffman A; Habib G; Gilhar D; Zohar H
Cyclosporin increases the CNS sensitivity to the hypnotic effect of phenobarbitone but not ethanol in rats.
The Journal of pharmacy and pharmacology 1994;46(9):760-4.
-
1994: Hoffman A; Habib G
Valproic acid intensifies the depressant action of phenobarbital and ethanol by a pharmacodynamic mechanism.
Journal of pharmaceutical sciences 1994;83(5):733-5.
-
1994: Hoffman A; Alfon J; Habib G; Pinto E; Gorodetsky R
The effect of immunosuppression by total-body irradiation on the pharmacodynamics of centrally active drugs in rats.
Pharmaceutical research 1994;11(5):704-8.
-
1994: Hoffman A; Alfon J; Siegal T; Siegal T
Pharmacodynamics of phenobarbital anesthesia and pentylenetetrazol-induced maximal seizures in a rat model of neoplastic spinal cord compression.
Pharmaceutical research 1994;11(4):536-40.
-
1994: Hoffman A; Pinto E; Afargan M; Schattner A
Cyclosporine enhances theophylline neurotoxicity in rats.
Journal of pharmaceutical sciences 1994;83(4):559-61.
-
1993: Hoffman A; Pinto E; Gilhar D
Effect of pretreatment with anticonvulsants on theophylline-induced seizures in the rat.
Journal of critical care 1993;8(4):198-202.
-
1993: Golomb G; Avramoff A; Hoffman A
A new route of drug administration: intrauterine delivery of insulin and calcitonin.
Pharmaceutical research 1993;10(6):828-33.
-
1993: Hoffman A; Levy G
Kinetics of drug action in disease states. XLI. Effect of adrenalectomy on the hypnotic activity of phenobarbital, the neurotoxicity of theophylline and pain sensitivity in rats.
The Journal of pharmacology and experimental therapeutics 1993;264(2):859-62.
-
1993: Hoffman A; Baluom M
Effect of acute experimental liver dysfunction on the pharmacodynamics of heptabarbital in rats.
Acta anaesthesiologica Scandinavica 1993;37(1):102-4.
-
1992: Hoffman A; Alfon J
High-dose methotrexate does not affect the pharmacodynamics of phenobarbital hypnotic action but decreases the central nervous system (CNS) sensitivity to pentylenetetrazol-induced maximal seizures in rats.
Pharmaceutical research 1992;9(10):1295-8.
-
1992: Hoffman A
Potential pharmacodynamic effect of charcoal on theophylline neurotoxicity in normal rats.
Pharmacology, biochemistry, and behavior 1992;43(2):621-3.
-
1992: Golomb G; Eitan Y; Hoffman A
Measurement of serum [3H]tetracycline kinetics and indices of kidney function facilitate study of the activity and toxic effects of bisphosphonates in bone resorption.
Pharmaceutical research 1992;9(8):1018-23.
-
1991: Hoffman A; Levy G
Kinetics of drug action in disease states. XL. Effect of the dialyzable component(s) of uremic blood on theophylline neurotoxicity in rats.
Pharmaceutical research 1991;8(3):415-7.
-
1990: Hoffman A; Levy G
Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.
Pharmaceutical research 1990;7(3):242-6.
-
1990: Donbrow M; Hoffman A; Benita S
Phase separation modulation and aggregation prevention: mechanism of the non-solvent addition method in the presence and absence of polyisobutylene as an additive.
Journal of microencapsulation 1990;7(1):1-15.
-
1990: Hoffman A; Levy G
Kinetics of drug action in disease states. XXXVI: Effect of cyclosporine on the pharmacodynamics and pharmacokinetics of a barbiturate (heptabarbital) in rats.
Journal of pharmaceutical sciences 1990;79(1):19-22.
-
1989: Hoffman A; Levy G
Gender differences in the pharmacodynamics of barbiturates in rats.
Pharmaceutical research 1989;6(11):976-81.
-
1989: Hoffman A; Levy G
Kinetics of drug action in disease states. XXIX. Effect of experimental nephrotic syndrome on the pharmacodynamics of heptabarbital: implications of severe hypoalbuminemia.
The Journal of pharmacology and experimental therapeutics 1989;249(1):117-22.
-
1989: Hoffman A; Levy G
Effect of enoxacin on theophylline neurotoxicity.
Life sciences 1989;44(23):1803-6.
-
1988: Benita S; Babay D; Hoffman A; Donbrow M
Relation between individual and ensemble release kinetics of indomethacin from microspheres.
Pharmaceutical research 1988;5(3):178-82.
-
1988: Donbrow M; Hoffman A; Benita S
Variation of population release kinetics in polydisperse multiparticulate systems (microcapsules, microspheres, droplets, cells) with heterogeneity of one, two or three parameters in the population of individuals.
The Journal of pharmacy and pharmacology 1988;40(2):93-6.
-
1986: Hoffman A; Donbrow M; Benita S
Direct measurements on individual microcapsule dissolution as a tool for determination of release mechanism.
The Journal of pharmacy and pharmacology 1986;38(10):764-6.
-
1985: Benita S; Hoffman A; Donbrow M
Polyacrylate resin (Eudragit retard) microcapsules as a controlled release drug delivery system-improved non-solvent addition phase separation process.
Journal of microencapsulation 1985;2(3):207-22.
-
1985: Benita S; Hoffman A; Donbrow M
Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model.
The Journal of pharmacy and pharmacology 1985;37(6):391-5.
Sign-in to see more
